Importance of Mevalonate Pathway Lipids on the Growth and Survival of Primary and Metastatic Gastric Carcinoma Cells
Clinical and Experimental Gastroenterology · 2021-05 · Volume 14 · 217-228
DOI: 10.2147/ceg.s310235 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Gastroenterology, 2021-05. Verfasst von Natalia Ortiz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Bioquímica, Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departamento de Bioquímica, Escuela de Medicina, Universidad de Costa Rica, San José, Costa Rica.
- Escuela de Biología, Universidad de Costa Rica, San José, Costa Rica.
- Instituto Clodomiro Picado, Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica.
Zitieren
APA
Ortiz, N., Delgado-Carazo, J. C., & Díaz, C. (2021). Importance of Mevalonate Pathway Lipids on the Growth and Survival of Primary and Metastatic Gastric Carcinoma Cells. Clinical and Experimental Gastroenterology, Volume 14, 217-228. https://doi.org/10.2147/ceg.s310235
Vancouver
Ortiz N, Delgado-Carazo JC, Díaz C. Importance of Mevalonate Pathway Lipids on the Growth and Survival of Primary and Metastatic Gastric Carcinoma Cells. Clinical and Experimental Gastroenterology. 2021;Volume 14:217-228. doi:10.2147/ceg.s310235
BibTeX
@article{Ortiz2021,
author = {Ortiz, Natalia and Delgado-Carazo, Juan Carlos and Díaz, Cecilia},
title = {Importance of Mevalonate Pathway Lipids on the Growth and Survival of Primary and Metastatic Gastric Carcinoma Cells},
journal = {Clinical and Experimental Gastroenterology},
year = {2021},
volume = {Volume 14},
pages = {217--228},
doi = {10.2147/ceg.s310235}
}
EUVIMED